Let’s start up with the current stock price of Akcea Therapeutics Inc. (AKCA), which is $18.19 to be very precise. The Stock rose vividly during the last session to $11.73 after opening rate of $11.73 while the lowest price it went was recorded $11.20 before closing at $11.38.
Recently in News on August 31, 2020, Block & Leviton LLP Investigates Proposed Acquisition Involving Akcea Therapeutics, Inc.; Shareholders Should Contact the Firm. BOSTON, MA / ACCESSWIRE / August 31, 2020 / Block & Leviton LLP (www.blockleviton.com), a national securities litigation firm, has opened an investigation into the proposed acquisition involving Akcea Therapeutics, Inc. (NASDAQ:AKCA). In this proposed acquisition, Akcea’s controlling shareholder, Ionis Pharmaceuticals, Inc., would acquire all of the outstanding shares of Akcea common stock that it does not already own for $18.15 per share in cash. Block & Leviton is investigating whether Ionis and/or members of the Akcea Board of Directors breached their fiduciary duties to ensure that the proposed transaction was entirely fair. Akcea shareholders should contact Block & Leviton for a free case evaluation. You can read further details here
Akcea Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $20.10 on 01/23/20, with the lowest value was $8.00 for the same time period, recorded on 03/16/20.
Akcea Therapeutics Inc. (AKCA) full year performance was -46.50%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Akcea Therapeutics Inc. shares are logging -20.18% during the 52-week period from high price, and 127.38% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $8.00 and $22.79.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 5056269 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Akcea Therapeutics Inc. (AKCA) recorded performance in the market was -32.82%, having the revenues showcasing -24.98% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.20B, as it employees total of 294 workers.
Analysts verdict on Akcea Therapeutics Inc. (AKCA)
During the last month, 2 analysts gave the Akcea Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 14.10, with a change in the price was noted +2.45. In a similar fashion, Akcea Therapeutics Inc. posted a movement of +15.60% for the period of last 100 days, recording 288,384 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for AKCA is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Akcea Therapeutics Inc. (AKCA): Technical Analysis
Raw Stochastic average of Akcea Therapeutics Inc. in the period of last 50 days is set at 84.86%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 84.86%. In the last 20 days, the company’s Stochastic %K was 70.01% and its Stochastic %D was recorded 67.58%.
Let’s take a glance in the erstwhile performances of Akcea Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -32.82%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -32.82%, alongside a downfall of -46.50% for the period of the last 12 months. The shares increased approximately by -3.48% in the 7-day charts and went down by -1.81% in the period of the last 30 days. Common stock shares were lifted by -24.98% during last recorded quarter.